| Literature DB >> 31199457 |
Jocelyne Piret1, Manuel Schibler2, Van Dung Pham3,4, Sébastien Hantz5,6,7, Federica Giannotti8, Stavroula Masouridi-Levrat8, Laurent Kaiser2, Nathalie Goyette1, Sophie Alain5,6,7, Rong Shi3,4, Guy Boivin1.
Abstract
We report a case of cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. A previously uncharacterized V787E mutation in UL54 was identified in cerebrospinal fluid but not plasma specimens. For the V787E recombinant virus, the half maximal effective concentrations for ganciclovir, foscarnet, and cidofovir were 8.6-, 3.4- and 2.9-fold higher than for wild-type virus, and the replicative capacity was lower. The introduction of a bulkier and negatively charged glutamate residue at position 787 could destabilize the finger domain of UL54 DNA polymerase. Viral genotyping of cerebrospinal fluid is warranted in subjects with cytomegalovirus encephalitis, owing to the low penetration of antivirals in this compartment.Entities:
Keywords: Cytomegalovirus; cerebrospinal fluid; compartmentalization; drug resistance; encephalitis; hematopoietic stem cell transplantation; recombinant phenotyping; replicative capacity; three-dimensional modeling
Mesh:
Substances:
Year: 2019 PMID: 31199457 PMCID: PMC6743826 DOI: 10.1093/infdis/jiz298
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226